Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Gen Surg SAQssurgical-critical-care

Gen Surg SAQs · surgical-critical-care

Day-2 post-laparotomy oliguria — stage, bundle, fluids and dialysis triggers

Fellowship SAQ on postoperative AKI: KDIGO staging bands, bundle prevention with BigpAK-2 NNT 12, RELIEF fluids restraint with balanced crystalloids, delayed-RRT triggers with the AKIKI-2 floor, and kidney-health follow-up after mild AKI.

10 marks12 min2 min readVerification in progress

Target exams

FRACSFRCS(Gen Surg)ABSFRCSC
On this page
Study tools

Target exams

FRACSFRCS(Gen Surg)ABSFRCSC
Prompt
A 68-year-old man is day 2 after emergency laparotomy: creatinine 88 to 161 micromol/L (1.8 times baseline), urine 0.4 mL/kg/h for 9 hours, mean arterial pressure 68 on low-dose noradrenaline, trough-targeted vancomycin running, contrast CT yesterday. (A) Stage the AKI by KDIGO with the exact bands, list the bedside risk factors present, and state the KDIGO bundle's four planks with the PrevAKI-to-BigpAK-2 numbers. (4 marks) (B) Prescribe fluids and pressure management using RELIEF, balanced-crystalloid and pressor-substitution evidence, and state your vancomycin and contrast plan. (3 marks) (C) Decide on RRT today using STARRT-AKI and AKIKI triggers, name the AKIKI-2 floor, and set follow-up given the 1-year mortality and creatinine-blindness evidence. (3 marks)

Write your answer

Saved on this device. No marking — you are the marker.

Model answer

(A) Stage 1 by both doors, high-risk by every factor, bundle by the trials (4 marks). Creatinine 1.8-fold sits in the 1.5–1.9 stage-1 band and 9 hours of urine below 0.5 mL/kg/h sits in the 6–12-hour stage-1 band — either alone defines AKI (0.3 mg/dL in 48 hours, 1.5-fold in 7 days, or 6-hour oliguria), and staging takes the worse of the two, which here agree.[1] He carries the full bedside risk set: older age, emergency major surgery, hypotension on pressors, vancomycin and contrast exposure — the cohorts' list (age, CKD, diabetes, heart failure, shock, nephrotoxins) applied to one patient.[4][5] Deploy the four-plank KDIGO bundle — haemodynamic optimisation with monitoring, volume restoration, nephrotoxin/contrast avoidance, no hyperglycaemia — quoting PrevAKI (55.1 versus 71.7%, ARR 16.6% single-centre) through BigpAK-2 (14.4 versus 22.3%, OR 0.57, NNT 12, multicentre, no harm).[18][19]

(B) Balanced liberal fluids, pressure floor with volume first, drugs reviewed (3 marks). Prescribe balanced crystalloids without overload and without RELIEF-style restriction (3.7 versus 6.1 L raised AKI 8.6 versus 5.0% with no survival gain) — balanced fluids beat saline on sepsis mortality (OR 0.84) and starch on AKI (OR 0.80) — holding MAP 65–70 per ESICM while giving volume before pressors, since both hypotension depth and cumulative noradrenaline independently predict AKI.[17][20][21] Switch vancomycin to AUC-guided dosing (less AKI than trough-guided, OR 0.625) and avoid further contrast and nephrotoxins per the bundle's third plank.[32][19]

(C) No dialysis today, triggers written, follow-up booked (3 marks). Without hyperkalaemia, acidosis, oedema, BUN above 112 or 72-hour oliguria, STARRT-AKI governs: accelerated RRT matched standard mortality (43.9 versus 43.7%) with more dependence and harm — and AKIKI shows half such patients never need dialysis — while ELAIN's early benefit stays quoted only as the contradicted single-centre outlier.[38][39][42] Write the five triggers and the AKIKI-2 floor (pushing past 72-hour oliguria/BUN 112 to BUN 140 gained nothing and raised death, HR 1.65).[40] Book focused kidney health assessment after discharge: even mild AKI carries adjusted 1-year mortality near trebled (HR 2.96), postoperative creatinine dips overestimate recovery, and follow-up is essential not optional.[10][4]

References14ShowHide
  1. [1]Kellum JA, et al. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care, 2013.PMID 23394211
  2. [4]Prowle JR, et al. Postoperative acute kidney injury in adult non-cardiac surgery: joint consensus report of the Acute Disease Quality Initiative and PeriOperative Quality Initiative. Nat Rev Nephrol, 2021.PMID 33976395
  3. [10]O'Connor ME, et al. Acute kidney injury and mortality 1 year after major non-cardiac surgery. Br J Surg, 2017.PMID 28218392
  4. [18]Meersch M, et al. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med, 2017.PMID 28110412
  5. [19]Zarbock A, et al. A preventive care strategy to reduce moderate or severe acute kidney injury after major surgery (BigpAK-2); a multinational, randomised clinical trial. Lancet, 2025.PMID 41242333
  6. [20]Myles PS, et al. Restrictive versus Liberal Fluid Therapy for Major Abdominal Surgery. N Engl J Med, 2018.PMID 29742967
  7. [21]Tseng CH, et al. Resuscitation fluid types in sepsis, surgical, and trauma patients: a systematic review and sequential network meta-analyses. Crit Care, 2020.PMID 33317590
  8. [32]Abdelmessih E, et al. Vancomycin area under the curve versus trough only guided dosing and the risk of acute kidney injury: Systematic review and meta-analysis. Pharmacotherapy, 2022.PMID 35869689
  9. [38]Bagshaw SM, Wald R, Adhikari NKJ, et al. Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury. N Engl J Med, 2020.PMID 32668114
  10. [39]Gaudry S, et al. Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit. N Engl J Med, 2016.PMID 27181456
  11. [40]Gaudry S, et al. Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial. Lancet, 2021.PMID 33812488
  12. [42]Zarbock A, et al. Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial. JAMA, 2016.PMID 27209269
  13. [17]Joannidis M, et al. Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017 : Expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine. Intensive Care Med, 2017.PMID 28577069
  14. [5]Zarbock A, et al. Update on Perioperative Acute Kidney Injury. Anesth Analg, 2018.PMID 30138176
PreviousDay-2 post-laparotomy multiorgan failure — score it, untangle crosstalk, sequence supportsurgical-critical-careNextPost-laparotomy shock gut with AKI and falling phosphate — dose, route, protein, refeeding and glucosesurgical-critical-care